Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ClearPoint Neuro, Inc.CLPT · Entity 2367 | Director · CEO and President | September 02, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ClearPoint Neuro, Inc.
Report date September 02, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 130,720 |
Reported balance
After 2026-09-02 transaction · row 1
1 source rowRow 1 · 2026-09-02 · Exercise / conversion · Acquired 12,517 · Balance 130,720 F1: Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.47 · Expires 2029-08-15 | Direct | 61,887 |
Reported balance
After 2026-09-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-02 · Exercise / conversion · Disposed 12,517 · Balance 61,887 F1: Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction. F3: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is August 15, 2019. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 191,388 |
Reported balance
Holding disclosure · report date 2026-09-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 191,388 F2: These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.
F2: These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
F3: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is August 15, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 29, 2023 Filed Jan 4, 2024 01:51 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 1,067 | $5.77 | $6,156.59 |
DisclosureSEC source: 0001285550-24-000011 · wk-form4_1704333050.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,726 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2023 through December 31, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first business day or last business day of the purchase period. Read SEC document |
| July 09, 2023 Filed Jul 11, 2023 20:32 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 6,122 | $6.58 | $40,282.76 |
DisclosureSEC source: 0001285550-23-000088 · wf-form4_168910751319479.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,659 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:47 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 2,095 | $6.15 | $12,884.25 |
DisclosureSEC source: 0001285550-23-000084 · wf-form4_168859366246419.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,781 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2023 through June 30, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. Read SEC document |
| June 10, 2023 Filed Jun 13, 2023 21:02 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 6,952 | $6.91 | $48,038.32 |
DisclosureSEC source: 0001285550-23-000070 · wf-form4_168669014858066.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,686 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:51 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 118,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-23-000030 · wf-form4_167831230569599.xml · derivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,518 Underlying: Common Stock · 118,518 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F3 · derivative.exercise_date: The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. F3 · derivative.expiration_date: The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:51 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantStock Options (right to buy) · Derivative | 39,506 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001285550-23-000030 · wf-form4_167831230569599.xml · derivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,506 Underlying: Common Stock · 39,506 shares Expires 2033-03-06 F1 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| August 20, 2022 Filed Aug 23, 2022 22:13 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 1,457 | $13.24 | $19,290.68 |
DisclosureSEC source: 0001285550-22-000051 · wf-form4_166129278397329.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,638 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:47 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | SaleCommon Stock | 18,867 | $16.07 | $303,192.69 |
DisclosureSEC source: 0001285550-22-000045 · wf-form4_166068282013601.xml · nonDerivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,095 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:47 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 7,778 | $16.02 | $124,603.56 |
DisclosureSEC source: 0001285550-22-000045 · wf-form4_166068282013601.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,962 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · balance_after: Includes 2,155 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan. Read SEC document |
| July 09, 2022 Filed Jul 12, 2022 23:04 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 6,664 | $14.24 | $94,895.36 |
DisclosureSEC source: 0001285550-22-000036 · wf-form4_165766703828158.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,585 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 20:15 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantStock Options (right to buy) · Derivative | 46,742 | $0.00 Strike: $11.41 | $0.00 |
DisclosureSEC source: 0001285550-22-000023 · wf-form4_165523769683678.xml · derivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,742 Underlying: Common Stock · 46,742 shares Expires 2032-06-10 F3 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 20:15 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 70,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-22-000023 · wf-form4_165523769683678.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,249 F1 · shares: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. F2 · balance_after: Includes 1,349 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 21:46 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | SaleCommon Stock | 10,000 | $16.88 | $168,800.00 |
DisclosureSEC source: 0001420506-21-001558 · doc4_978.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,787 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 21, 2021 Filed Sep 21, 2021 20:40 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | SaleCommon Stock | 9,637 | $17.98 | $173,273.26 |
DisclosureSEC source: 0001420506-21-001352 · doc4_967.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,787 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 20:07 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantStock Options (right to buy) · Derivative | 29,377 | $0.00 Strike: $16.71 | $0.00 |
DisclosureSEC source: 0001420506-21-001337 · doc4_963.xml · derivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,377 Underlying: Common Stock · 29,377 shares Expires 2031-08-20 F2 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 20:07 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 14,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001420506-21-001337 · doc4_963.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,424 F1 · shares: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 21:07 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 7,353 | $17.70 | $130,148.10 |
DisclosureSEC source: 0001420506-21-001323 · doc4_957.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,736 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 20:11 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 3,277 | $18.54 | $60,755.58 |
DisclosureSEC source: 0001420506-21-000869 · doc4_949.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,089 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 22:49 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | SaleCommon Stock | 25,000 | $18.57 | $464,250.00 |
DisclosureSEC source: 0001420506-21-000838 · doc4_935.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,366 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 07, 2020 Filed Nov 9, 2020 21:13 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 14,286 | $6.65 | $95,001.90 |
DisclosureSEC source: 0001420506-20-001168 · doc4_881.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,845 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 07, 2020 Filed Jan 5, 2021 21:04 UTC Amendment | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 5,765 | $6.65 | $38,337.25 |
DisclosureSEC source: 0001420506-21-000014 · doc4a_900.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,366 F1 · shares: This amendment on Form 4/A to the original Form 4 filed on November 7, 2020 is made solely to correct the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted Read SEC document |
| August 15, 2020 Filed Aug 18, 2020 20:26 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 2,491 | $4.10 | $10,213.10 |
DisclosureSEC source: 0001420506-20-000996 · doc4_841.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,131 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:09 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 5,763 | $4.00 | $23,052.00 |
DisclosureSEC source: 0001420506-20-000853 · doc4_840.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,622 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 20:07 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantStock Options (right to buy) · Derivative | 52,356 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001420506-20-000713 · doc4_828.xml · derivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,356 Underlying: Common Stock · 52,356 shares Expires 2030-07-09 F2 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 20:07 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 30,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001420506-20-000713 · doc4_828.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,385 F1 · shares: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| May 07, 2020 Filed May 8, 2020 23:00 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 6,627 | $3.69 | $24,453.63 |
DisclosureSEC source: 0001420506-20-000473 · doc4_801.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,521 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 14:29 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | Tax withholdingCommon Stock | 5,590 | $5.30 | $29,627.00 |
DisclosureSEC source: 0001420506-20-000135 · doc4_786.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,148 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock Read SEC document |
| November 07, 2019 Filed Nov 12, 2019 13:40 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | Tax withholdingCommon Stock | 5,590 | $3.87 | $21,633.30 |
DisclosureSEC source: 0001534424-19-000301 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,738 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantStock Options (right to buy) · Derivative | 74,404 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0001534424-19-000241 · ownership.xml · derivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,404 Underlying: Common Stock · 74,404 shares Expires 2029-08-15 F2 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantCommon Stock | 36,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001534424-19-000241 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,328 F1 · shares: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 20:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | Tax withholdingCommon Stock | 5,590 | $4.26 | $23,813.40 |
DisclosureSEC source: 0001534424-19-000227 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,305 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 07, 2019 Filed May 8, 2019 20:28 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | Tax withholdingCommon Stock | 5,590 | $3.10 | $17,329.00 |
DisclosureSEC source: 0001534424-19-000132 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,895 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 21:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | Tax withholdingCommon Stock | 6,475 | $2.75 | $17,806.25 |
DisclosureSEC source: 0001534424-19-000064 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,538 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 21:55 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | Tax withholdingCommon Stock | 8,304 | $2.55 | $21,175.20 |
DisclosureSEC source: 0001534424-19-000045 · ownership.xml · nonDerivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,013 Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 21:55 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantCommon Stock | 20,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001534424-19-000045 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,317 F1 · price: The Reporting Person received a portion of his 2018 cash bonus in the form of the Company's common stock based on the closing sales price of the Company's common stock on January 23, 2019. The shares were granted under the Company's Second Amended and Restated 2013 Incentive Compensation Plan. Read SEC document |
| November 07, 2018 Filed Feb 27, 2019 21:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | Tax withholdingCommon Stock | 23,053 | $2.00 | $46,106.00 |
DisclosureSEC source: 0001534424-19-000069 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,485 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| September 25, 2018 Filed Sep 25, 2018 21:23 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | PurchaseCommon Stock | 25,000 | $1.25 | $31,250.00 |
DisclosureSEC source: 0001534424-18-000318 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,004 Read SEC document |
| August 24, 2018 Filed Aug 24, 2018 20:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | PurchaseCommon Stock | 7,500 | $1.58 | $11,850.00 |
DisclosureSEC source: 0001534424-18-000288 · ownership.xml · nonDerivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,504 Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 20:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | PurchaseCommon Stock | 4,637 | $1.55 | $7,187.35 |
DisclosureSEC source: 0001534424-18-000288 · ownership.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,004 F1 · balance_after: This amount corrects a typographical error, which inadvertently overstated the reporting person's holdings, in the previously filed Form 4. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantCommon Stock | 18,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001534424-18-000173 · burnett.xml · nonDerivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 576,367 F1 · price: The Reporting Person received the final $50,000 portion of his signing bonus in the form of the Company's common stock based on the closing price as of May 22, 2018. The shares were granted under the Company's Second Amended and Restated 2013 Incentive Compensation Plan. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:05 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | PurchaseCommon Stock | 7,500 | $2.39 | $17,902.50 |
DisclosureSEC source: 0001534424-18-000173 · burnett.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,500 Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 21:37 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantStock Options (right to buy) · Derivative | 350,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001534424-17-000461 · burnett.xml · derivative · entry 2 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2027-11-07 F2 · derivative.exercise_date: The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 21:37 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001534424-17-000461 · burnett.xml · nonDerivative · entry 1 BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · price: The shares are restricted stock and vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.